Chemotherapeutic activity of the combination of trimethoprim and sulphamethoxazole in infections of mice.
D000818:Animals; D004357:Drug Synergism; D004927:Escherichia coli Infections / Q000188:drug therapy; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D006192:Haemophilus Infections / Q000188:drug therapy; D007239:Infections / Q000188:drug therapy*; D008589:Meningococcal Infections / Q000188:drug therapy; D051379:Mice; D011008:Pneumococcal Infections / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000627:therapeutic use*
D005493:Folic Acid Antagonists; D011743:Pyrimidines; D013420:Sulfamethoxazole